z-logo
open-access-imgOpen Access
CypA, a Gene Downstream of HIF-1α, Promotes the Development of PDAC
Author(s) -
Huan Zhang,
Jing Chen,
Fenghua Li,
Chuntao Gao,
Xiuchao Wang,
Tiansuo Zhao,
Jingcheng Liu,
Song Gao,
Xiao Ling Zhao,
He Ren,
Jihui Hao
Publication year - 2014
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0092824
Subject(s) - cypa , cancer research , transcription factor , biology , chromatin immunoprecipitation , apoptosis , cell growth , gene expression , microbiology and biotechnology , cyclophilin a , gene , promoter , biochemistry , genetics
Hypoxia-inducible factor-1α (HIF-1α) is a highly important transcription factor involved in cell metabolism. HIF-1α promotes glycolysis and inhibits of mitochondrial respiration in pancreatic ductal adenocarcinoma (PDAC). In response to tumor hypoxia, cyclophilin A (CypA) is over-expressed in various cancer types, and is associated with cell apoptosis, tumor invasion, metastasis, and chemoresistance in PDAC. In this study, we showed that both HIF-1α and CypA expression were significantly associated with lymph node metastasis and tumor stage. The expression of CypA was correlated with HIF-1α. Moreover, the mRNA and protein expression of CypA markedly decreased or increased following the suppression or over-expression of HIF-1α in vitro. Chromatin immunoprecipitation analysis showed that HIF-1α could directly bind to the hypoxia response element (HRE) in the CypA promoter regions and regulated CypA expression. Consistent with other studies, HIF-1α and CypA promoted PDAC cell proliferation and invasion, and suppressed apoptosis in vitro. Furthermore, we proved the combination effect of 2-methoxyestradiol and cyclosporin A both in vitro and in vivo. These results suggested that,CypA, a gene downstream of HIF-1α, could promote the development of PDAC. Thus, CypA might serve as a potential therapeutic target for PDAC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here